日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study Ann Rheum Dis. 2023;82:1404-1414

关于在未接受过生物制剂DMARD治疗的活动性银屑病关节炎患者中应用Bimekizumab治疗的更正:来自III期随机、安慰剂对照、活性参考BE OPTIMAL研究的52周疗效和安全性结果 Ann Rheum Dis. 2023;82:1404-1414

Ritchlin, Christopher T; Coates, Laura C; McInnes, Iain B; Mease, Philip J; Merola, Joseph F; Tanaka, Yoshiya; Asahina, Akihiko; Gossec, Laure; Gottlieb, Alice B; Warren, Richard B; Ink, Barbara; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Landewé, Robert B M

Genetic analysis of neurodegenerative diseases

神经退行性疾病的基因分析

Grassano, Maurizio; Schindler, Alice B; Traynor, Bryan J; Scholz, Sonja W

Gene and allele-specific expression during electric organ ontogeny in African weakly electric fish (Campylomormyrus)

非洲弱电鱼(Campylomormyrus)电器官发育过程中基因和等位基因特异性表达

Cheng, Feng; Dennis, Alice B; Nguyen, Linh; Baumann, Otto; Kirschbaum, Frank; Domínguez, Marisol; Tiedemann, Ralph

Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year

比美珠单抗治疗伴有严重皮肤和指甲银屑病的银屑病关节炎患者的疗效和安全性(长达 1 年)

Thaçi, Diamant; Asahina, Akihiko; Boehncke, Wolf-Henning; Gottlieb, Alice B; Lebwohl, Mark; Warren, Richard B; Edens, Heather; Ink, Barbara; Bajracharya, Rajan; Coarse, Jason; Merola, Joseph F

Real-World Burden of Generalized Pustular Psoriasis in a French Observational Study: Prevalence, Incidence, Healthcare Resource Utilization, Comorbidities, Treatment Use, and Mortality

法国一项观察性研究揭示了泛发性脓疱型银屑病的真实世界负担:患病率、发病率、医疗资源利用、合并症、治疗使用情况和死亡率

Viguier, Manuelle; Jullien, Denis; Misery, Laurent; Kromer, Christian; Mockenhaupt, Maja; Lakshminarasimhan, Bhargav; Najean, Marie; Pillai, Nichiren; Khan, Shah Alam; Gottlieb, Alice B

Fighting for Chemicals: Pharmacophagy-Induced Contest Behaviour and Its Molecular Signatures in a Sawfly

争夺化学物质:锯蝇中由药物吞噬引起的竞争行为及其分子特征

Paul, Sarah C; Dennis, Alice B; Tewes, Lisa Johanna; Friedrichs, Jeanne; Singh, Pragya; Müller, Caroline

Secukinumab in the Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Pooled Pharmacokinetics and Safety Results From the SUNSHINE and SUNRISE Phase 3 Studies

司库奇尤单抗治疗中重度化脓性汗腺炎:SUNSHINE 和 SUNRISE 3 期研究的汇总药代动力学和安全性结果

Alavi, Afsaneh; Reguiai, Ziad; Jemec, Gregor B E; Gottlieb, Alice B; Wozniak, Magdalena B; Uhlmann, Lorenz; Fan, Heng; Llobet Martinez, Angela; Bruin, Gerard; Thomas, Nicolas; Alarcon, Ivette; Bieth, Bruno; Ravichandran, Shoba; Kimball, Alexa B

Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension

比美珠单抗治疗斑块状银屑病三年患者报告结局:BE RADIANT 随机临床试验及开放标签扩展研究

Augustin, Matthias; Feldman, Steven R; Warren, Richard B; Armstrong, April; Vender, Ronald; López-Ferrer, Anna; Dawe, William H; Lambert, Jérémy; Szilagyi, Balint; Hoepken, Bengt; Warham, Rhys; Gottlieb, Alice B

Comparative Risk of Infection and Prevalence of Combination Targeted Therapy in Psoriatic Arthritis

银屑病关节炎患者感染风险比较及联合靶向治疗的普及率

Wu, Alexander; Zhang, Arianna; Guo, Yujia; Liu, Jialiang; Yang, Donghan M; Chada, Lourdes Perez; Ogdie, Alexis; Reddy, Soumya M; Gottlieb, Alice B; Scher, Jose U; Merola, Joseph F

Ixekizumab and Malignant Neoplasms: A Pooled Analysis of Data From 25 Randomized Clinical Trials

伊克珠单抗与恶性肿瘤:25项随机临床试验数据的汇总分析

Merola, Joseph F; Papp, Kim A; Deodhar, Atul; Blauvelt, Andrew; Kronbergs, Andris; Feely McDonald, Meghan; Eberhart, Nadezdha; Zhu, Danting; Inman, Elsa; Grace, Elsie; Holzkaemper, Thorsten; Rahman, Proton; Marzo-Ortega, Helena; Gottlieb, Alice B; Schwartzman, Sergio; Lebwohl, Mark